While genetic analyses found a positive association between raised risk of depressive mood and circulating levels of PCSK9, the notion that lipid-lowering drugs might increase the risk of depression was not confirmed in trials with PCSK9 inhibitors [51]. Here, PCSK9 is linked to major depressive disorder.